JOINDER AGREEMENTJoinder Agreement • April 30th, 2015 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
This Joinder Agreement is dated as of April 1, 2015 (this “Agreement”), by and among each of the financial institutions set forth on Schedule A annexed hereto (each a “New Term Loan Lender” and collectively the “New Term Loan Lenders”), Valeant Pharmaceuticals International, Inc., a corporation continued under the laws of the Province of British Columbia (“Borrower”), the undersigned subsidiaries of Borrower and Barclays Bank PLC (“Barclays”), as Administrative Agent and Collateral Agent.
JOINDER AGREEMENTJoinder Agreement • April 30th, 2015 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
This Joinder Agreement is dated as of April 1, 2015 (this “Agreement”), by and among each of the financial institutions set forth on Schedule A annexed hereto (each a “Series F-1 New Term Loan Lender” and collectively the “Series F-1 New Term Loan Lenders”), each of the financial institutions set forth on Schedule B annexed hereto (each a “Series F-2 New Term Loan Lender” and collectively the “Series F-2 New Term Loan Lenders”; collectively, with the Series F-1 New Term Loan Lenders, the “New Term Loan Lenders” and each a “New Term Loan Lender”), Valeant Pharmaceuticals International, Inc., a corporation continued under the laws of the Province of British Columbia (“Borrower”), the undersigned subsidiaries of Borrower and Barclays Bank PLC (“Barclays”), as Administrative Agent and Collateral Agent.
